Steroid-refractory acute GVHD: Predictors and outcomes

Advances in Hematology

Volumn 2011, Issue , 2011, Pages

  Westin, Jason R ^a   Saliba, Rima M ^a   De Lima, Marcos ^a   Alousi, Amin ^a   Hosing, Chitra ^a   Qazilbash, Muzaffar H ^a   Khouri, Issa F ^a   Shpall, Elizabeth J ^a   Anderlini, Paolo ^a   Rondon, Gabriela ^a   Andersson, Borje S ^a   Champlin, Richard ^a   Couriel, Daniel R ^b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BASILIXIMAB; CORTICOSTEROID; DACLIZUMAB; INFLIXIMAB; METHOTREXATE; METHYLPREDNISOLONE; PENTOSTATIN; TACROLIMUS; THYMOCYTE ANTIBODY;

ACUTE GRAFT VERSUS HOST DISEASE; ADULT; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CAUSE OF DEATH; CORTICOSTEROID THERAPY; DISEASE SEVERITY; DRUG TREATMENT FAILURE; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN TISSUE; HYPERACUTE GRAFT VERSUS HOST DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MYELOABLATIVE CONDITIONING; OVERALL SURVIVAL; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; REDUCED INTENSITY CONDITIONING; RETROSPECTIVE STUDY; RISK FACTOR; SCORING SYSTEM; TREATMENT OUTCOME; TREATMENT RESPONSE; WHOLE BODY RADIATION;

EID: 84855296444     PISSN: 16879104     EISSN: 16879112     Source Type: Journal    
DOI: 10.1155/2011/601953     Document Type: Article

References (17)

1. Couriel D., Caldera H., Champlin R., Komanduri K., Acute graft-versus-host disease: pathophysiology, clinical manifestations, and management Cancer 2004 101 9 1936 1946 (Pubitemid 39425368)
2. Martin P. J., Schoch G., Fisher L., Byers V., Anasetti C., Appelbaum F. R., Beatty P. G., Doney K., McDonald G. B., Sanders J. E., Sullivan K. M., Storb R., Thomas E. D., Witherspoon R. P., Lomen P., Hannigan J., Hansen J. A., A retrospective analysis of therapy for acute graft-verus-host disease: initial treatment Blood 1990 76 8 1464 1472 (Pubitemid 20364008)
3. Martin P. J., Bachier C. R., Klingemann H. G., McCarthy P. L., Szabolcs P., Uberti J. P., Schuster M. W., Weisdorf D., Chao N. J., Kebriaei P., Shpall E. J., MacMillan M. L., Soiffer R. J., Endpoints for clinical trials testing treatment of acute graft-versus-host disease: a joint statement Biology of Blood and Marrow Transplantation 2009 15 7 777 784
4. Arai S., Margolis J., Zahurak M., Anders V., Vogelsang G. B., Poor outcome in steroid-refractory graft-versus-host disease with antithymocyte globulin treatment Biology of Blood and Marrow Transplantation 2002 8 3 155 160 (Pubitemid 34285074)
5. Saliba R. M., Couriel D. R., Giralt S., Rondon G., Okoroji G. -J., Rashid A., Champlin R. E., Alousi A. M., Prognostic value of response after upfront therapy for acute GVHD. Bone Marrow Transplantation. In press
6. Levine J. E., Logan B., Wu J., Alousi A. M., Ho V., Bolaos-Meade J., Weisdorf D., Graft-versus-host disease treatment: predictors of survival Biology of Blood and Marrow Transplantation 2010 16 12 1693 1699
7. MacMillan M. L., DeFor T. E., Weisdorf D. J., The best endpoint for acute GVHD treatment trials Blood 2010 115 26 5412 5417
8. Saliba R. M., De Lima M., Giralt S., Andersson B., Khouri I. F., Hosing C., Ghosh S., Neumann J., Hsu Y., De Jesus J., Qazilbash M. H., Champlin R. E., Couriel D. R., Hyperacute GVHD: risk factors, outcomes, and clinical implications Blood 2007 109 7 2751 2758 (Pubitemid 46482067)
9. Champlin R., Khouri I., Shimoni A., Gajewski J., Kornblau S., Molldrem J., Ueno N., Giralt S., Anderlini P., Harnessing graft-versus-malignancy: non-myeloablative preparative regimens for allogeneic haematopoietic transplantation, an evolving strategy for adoptive immunotherapy British Journal of Haematology 2000 111 1 18 29
10. Giralt S., Ballen K., Rizzo D., Bacigalupo A., Horowitz M., Pasquini M., Sandmaier B., Reduced-intensity conditioning regimen workshop: defining the dose spectrum. Report of a workshop convened by the center for international blood and marrow transplant research Biology of Blood and Marrow Transplantation 2009 15 3 367 369
11. Przepiorka D., Weisdorf D., Martin P., Klingemann H. G., Beatty P., Hows J., Thomas E. D., Consensus conference on acute GVHD grading Bone Marrow Transplantation 1995 15 6 825 828
12. Cox D., Regression models and life-tables Journal of the Royal Statistical Society Series B 1972 34 2 187 220
13. Prentice R. L., Kalbfleisch J. D., Peterson A. V., The analysis of failure times in the presence of competing risks Biometrics 1978 34 4 541 554 (Pubitemid 9067879)
14. Paczesny S., Krijanovski O. I., Braun T. M., Choi S. W., Clouthier S. G., Kuick R., Misek D. E., Cooke K. R., Kitko C. L., Weyand A., Bickley D., Jones D., Whitfield J., Reddy P., Levine J. E., Hanash S. M., Ferrara J. L. M., A biomarker panel for acute graft-versus-host disease Blood 2009 113 2 273 278
15. MacMillan M. L., Weisdorf D. J., Wagner J. E., DeFor T. E., Burns L. J., Ramsay N. K. C., Davies S. M., Blazar B. R., Response of 443 patients to steroids as primary therapy for acute graft-versus-host disease: comparison of grading systems Biology of Blood and Marrow Transplantation 2002 8 7 387 394
16. Weisdorf D., Haake R., Blazar B., Miller W., McGlave P., Ramsay N., Kersey J., Filipovich A., Treatment of moderate/severe acute graft-versus-host disease after allogeneic bone marrow transplantation: an analysis of clinical risk features and outcome Blood 1990 75 4 1024 1030 (Pubitemid 20067206)
17. Paczesny S., Choi S. W., Ferrara J. L. M., Acute graft-versus-host disease: new treatment strategies Current Opinion in Hematology 2009 16 6 427 436